ストックスクリーナーアプリを入手
2.00
4.31%
-0.09
前日終値:
$2.09
開ける：
$2.08
24時間の取引高:
1.70M
Relative Volume:
0.66
時価総額：
$329.83M
収益：
$101.21M
当期純損益:
$-569.00K
株価収益率:
-100.00
EPS:
-0.02
ネットキャッシュフロー:
$-56.88M
1週間 パフォーマンス:
-12.28%
1か月 パフォーマンス:
+7.53%
6か月 パフォーマンス:
+234.00%
1年 パフォーマンス:
+60.00%
1日の値動き範囲:
$2.00
$2.115
1週間の範囲:
$2.00
$2.30
52週間の値動き範囲:
$0.40
$3.095
Cytomx Therapeutics Inc Stock (CTMX) Company Profile
名前
Cytomx Therapeutics Inc
セクター
電話
650.515.3185
住所
151 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
CTMX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CTMX
Cytomx Therapeutics Inc
|
2.00 | 341.37M | 101.21M | -569.00K | -56.88M | -0.02 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cytomx Therapeutics Inc Stock (CTMX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-31 | 開始されました | Oppenheimer | Outperform |
| 2025-05-15 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-04-14 | 再開されました | Piper Sandler | Overweight |
| 2024-05-28 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-05-09 | アップグレード | Wedbush | Neutral → Outperform |
| 2024-05-06 | アップグレード | Jefferies | Hold → Buy |
| 2024-04-22 | アップグレード | JP Morgan | Underweight → Neutral |
| 2022-11-14 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-07-07 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-07 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-07-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-07-07 | ダウングレード | Wedbush | Outperform → Neutral |
| 2022-06-24 | 開始されました | BMO Capital Markets | Outperform |
| 2022-01-18 | アップグレード | Barclays | Underweight → Overweight |
| 2021-11-15 | 開始されました | BTIG Research | Buy |
| 2021-05-28 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2021-03-29 | 開始されました | JP Morgan | Overweight |
| 2021-03-23 | アップグレード | Jefferies | Hold → Buy |
| 2020-09-22 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-06-01 | ダウングレード | Jefferies | Buy → Hold |
| 2020-05-14 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-24 | アップグレード | Wedbush | Neutral → Outperform |
| 2020-03-04 | 開始されました | Barclays | Equal Weight |
| 2019-11-20 | 開始されました | Guggenheim | Buy |
| 2019-11-11 | ダウングレード | Wedbush | Outperform → Neutral |
| 2019-06-13 | 開始されました | Mizuho | Buy |
| 2019-05-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-03-11 | 開始されました | Barclays | Overweight |
| 2018-11-26 | 開始されました | Piper Jaffray | Overweight |
| 2018-10-15 | 開始されました | Goldman | Neutral |
| 2018-09-13 | 開始されました | H.C. Wainwright | Buy |
| 2018-06-01 | 開始されました | SunTrust | Buy |
| 2018-01-05 | 開始されました | Citigroup | Buy |
| 2017-09-08 | 開始されました | Wedbush | Outperform |
| 2017-03-27 | 開始されました | H.C. Wainwright | Buy |
| 2017-03-02 | 開始されました | Instinet | Buy |
| 2017-01-03 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2015-11-02 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Cytomx Therapeutics Inc (CTMX) 最新ニュース
CytomX Therapeutics (NASDAQ:CTMX) Shares Pass Below 50-Day Moving AverageShould You Sell? - MarketBeat
CytomX at Morgan Stanley Conference: Innovative Oncology Advances - Investing.com
Transcript : CytomX Therapeutics, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-10-2025 01 - MarketScreener
Is CytomX Therapeutics Inc. stock showing strong momentumVolume Spike & Technical Buy Zone Confirmations - Lancaster City Council
Can CytomX Therapeutics Inc. navigate macro headwindsJuly 2025 Macro Moves & Verified Trade Idea Suggestions - Lancaster City Council
Published on: 2025-09-09 06:04:45 - beatles.ru
RA Capital Management L.P. Invests $636,000 in CytomX Therapeutics, Inc. $CTMX - MarketBeat
CytomX Therapeutics Inc.’s volatility index tracking explained2025 Top Decliners & Safe Capital Growth Tips - Newser
How to recover losses in CytomX Therapeutics Inc. stockWeekly Trend Summary & Verified Momentum Stock Ideas - Newser
Is CytomX Therapeutics Inc. stock bottoming out2025 Pullback Review & Reliable Breakout Forecasts - Newser
CytomX Therapeutics Inc. Building a Base Near Support2025 Buyback Activity & Entry Point Strategy Guides - beatles.ru
Is CytomX Therapeutics Inc. forming higher highs and higher lowsBear Alert & Short-Term Swing Trade Alerts - خودرو بانک
Will CytomX Therapeutics Inc. benefit from AI trendsPortfolio Risk Summary & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Can CytomX Therapeutics Inc. maintain sales growthJuly 2025 Market Mood & Technical Buy Zone Confirmation - خودرو بانک
Identifying reversal signals in CytomX Therapeutics Inc.2025 Historical Comparison & Risk Controlled Daily Plans - Newser
News impact scoring models applied to CytomX Therapeutics Inc.July 2025 Spike Watch & Expert Approved Momentum Trade Ideas - Newser
How to forecast CytomX Therapeutics Inc. trends using time seriesJuly 2025 Gainers & Community Supported Trade Ideas - Newser
Should you hold or exit CytomX Therapeutics Inc. nowTrade Risk Assessment & Reliable Price Action Trade Plans - Newser
Historical volatility pattern of CytomX Therapeutics Inc. visualizedMarket Growth Summary & Free High Accuracy Swing Entry Alerts - Newser
Statistical indicators supporting CytomX Therapeutics Inc.’s strengthWeekly Loss Report & Consistent Return Strategy Ideas - Newser
Can you recover from losses in CytomX Therapeutics Inc.Market Movement Recap & Fast Entry Momentum Alerts - Newser
Is CytomX Therapeutics Inc. vulnerable to short sellersQuarterly Investment Review & Safe Capital Allocation Plans - خودرو بانک
Sentiment analysis tools applied to CytomX Therapeutics Inc.Quarterly Portfolio Report & Consistent Return Strategy Ideas - Newser
CytomX Therapeutics Inc. stock trend forecast2025 Macro Impact & AI Forecasted Stock Moves - Newser
Will CytomX Therapeutics Inc. stock recover after recent dropInsider Selling & Weekly Chart Analysis and Guides - Newser
Real time social sentiment graph for CytomX Therapeutics Inc.July 2025 Movers & High Accuracy Swing Entry Alerts - Newser
Technical analysis overview for CytomX Therapeutics Inc. stock2025 Bull vs Bear & Momentum Based Trading Signals - Newser
What institutional flow reveals about CytomX Therapeutics Inc.Market Performance Recap & Real-Time Sentiment Analysis - Newser
Is CytomX Therapeutics Inc. showing signs of accumulationJuly 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
Will CytomX Therapeutics Inc. benefit from macro trends2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
CytomX Therapeutics Inc. stock trendline breakdownJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - Newser
Leading vs lagging indicators on CytomX Therapeutics Inc. performanceMarket Growth Review & Accurate Technical Buy Alerts - Newser
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q2 2025 Earnings Call Transcript - MSN
Published on: 2025-09-03 09:30:47 - Newser
What earnings revisions data tells us about CytomX Therapeutics Inc.Weekly Stock Recap & Long-Term Growth Plans - Newser
Published on: 2025-09-03 13:30:24 - beatles.ru
What earnings revisions data tells us about CytomX Therapeutics IncJuly 2025 Levels & Weekly Momentum Stock Picks - Newser
CytomX Therapeutics (NASDAQ:CTMX) Stock Crosses Below Fifty Day Moving AverageHere's Why - MarketBeat
Will Windtree Therapeutics Inc. outperform during market ralliesJuly 2025 Short Interest & Fast Moving Trade Plans - خودرو بانک
Market Outlook: Will CytomX Therapeutics Inc. benefit from AI trendsJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Is CytomX Therapeutics Inc. trading at a discountJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - خودرو بانک
Will CytomX Therapeutics Inc. bounce back from current supportPortfolio Risk Report & Safe Entry Trade Signal Reports - Newser
Cytomx Therapeutics Inc (CTMX) 財務データ
収益
当期純利益
現金流量
EPS
Cytomx Therapeutics Inc (CTMX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Ogden Christopher | Chief Financial Officer |
Jun 16 '25 |
Sale |
2.69 |
10,614 |
28,540 |
226,271 |
| Ogden Christopher | Chief Financial Officer |
Jun 13 '25 |
Sale |
2.95 |
1,641 |
4,841 |
199,385 |
| BELVIN MARCIA | SVP, Chief Scientific Officer |
Jun 13 '25 |
Option Exercise |
0.00 |
37,500 |
0 |
286,136 |
| BELVIN MARCIA | SVP, Chief Scientific Officer |
Jun 16 '25 |
Sale |
2.69 |
13,884 |
37,334 |
272,252 |
| McCarthy Sean A. | CEO |
Jun 13 '25 |
Option Exercise |
0.00 |
150,000 |
0 |
1,145,195 |
| McCarthy Sean A. | CEO |
Jun 16 '25 |
Sale |
2.69 |
55,511 |
149,264 |
1,089,684 |
| McCarthy Sean A. | CEO |
Mar 18 '25 |
Sale |
0.60 |
37,656 |
22,556 |
995,195 |
| Ogden Christopher | Chief Financial Officer |
Mar 18 '25 |
Sale |
0.60 |
8,551 |
5,122 |
201,026 |
| Chu Yu-Waye | Chief Medical Officer |
Mar 18 '25 |
Sale |
0.60 |
4,025 |
2,411 |
135,725 |
| ROWLAND LLOYD A | General Counsel |
Mar 18 '25 |
Sale |
0.60 |
10,203 |
6,112 |
120,594 |
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):